LABU — Direxion Daily S&P Biotech Bull 3X Shares

PCX · Health Care · Trading · CIK ·
Last close
$178.62
Market Cap
52W High
$212.45
52W Low
$133.96
ADV30
601,750
Next earnings
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
No quarterly fundamentals indexed for this ticker.

Max Pain — expiry 2026-06-18

max pain strike: $170.00 · spot: $188.53 · call oi: 4,644 · put oi: 5,026
Expected Move to 2026-06-18: ±$13.00 (6.90%) — implied range $175.53$201.53 · ATM straddle on $189.00 strike

News headlines (Yahoo Finance, 1h cache)

LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout
2026-04-27 19:33 · Yahoo
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here’s How to Position Now
2026-04-23 17:22 · Yahoo
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026
2026-01-16 13:06 · Yahoo
Best-Performing Leveraged ETFs of October
2025-11-04 12:41 · Yahoo
Leveraged ETF Areas of Last Week That Are Up At least 15%
2025-09-08 12:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.